Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
European League Against Rheumatism (EULAR) 2019 Congress
June 12 - 15, 2019; Madrid, Spain
June 12 - 15, 2019Madrid, Spain
EULAR 2019New JAK Inhibitor Hits Rheumatoid Arthritis TargetsFilgotinib is effective and well tolerated by patients with moderate to severe rheumatoid arthritis, early phase 3 results show, and investigators speculate it will enter the market in about 2 years.
NSAIDs Increase Cardiovascular Risk in OsteoarthritisNonsteroidal anti-inflammatory drugs contribute to the elevated risk for cardiovascular disease in people with osteoarthritis,
new research shows, but alternatives for pain management are limited.
Medscape Medical News, Jun 15, 2018
Canakinumab Halves Gout in Patients With AtherosclerosisHowever, the interleukin-1 inhibitor has no effect on serum urate, which is a risk marker for both gout and cardiovascular
disease, a new analysis of data from CANTOS shows.
Medscape Medical News, Jun 22, 2018
Ankylosing Spondylitis Patients at Risk for Self-HarmPeople with this painful condition that affects the spine are at higher risk of harming themselves, a large study confirms;
however, the mental health effects of the disease are often ignored.
